Oxycaine Ophthalmic Solution 0.4% is a local anesthetic used primarily for its topical effects. It is commonly utilized in ophthalmology for ocular procedures and in other areas where localized anesthesia is required. It provides numbing effects by blocking nerve impulses in the targeted area.
Oxycaine Ophthalmic Solution 0.4% is used for:
| Brand Name | Oxycaine |
|---|---|
| Type | Ophthalmic Solution |
| Weight | 0.4% |
| Generic | Oxybuprocaine Hydrochloride |
| Manufacturer | Reman Drug Laboratories Ltd. |
| Available in | English বাংলা |
Oxycaine Ophthalmic Solution 0.4% works by blocking voltage-gated sodium channels in the nerve fibers, preventing the transmission of nerve impulses. This blockage results in temporary loss of sensation in the area where it is applied, thereby providing local anesthesia.
The onset of action for Oxycaine Ophthalmic Solution 0.4% is typically within 1 to 2 minutes after application. The anesthetic effect generally lasts for about 15 to 30 minutes, depending on the dosage and the specific procedure.
When applied topically to the eye, Oxycaine Ophthalmic Solution 0.4% is minimally absorbed into systemic circulation. Its primary effect is localized to the site of application, with minimal systemic absorption expected.
Oxycaine Ophthalmic Solution 0.4% is metabolized primarily in the liver. The drug and its metabolites are then excreted through the urine. Due to its topical application, systemic exposure is minimal, and elimination is generally not a concern for most patients.
The dosage of Oxycaine Ophthalmic Solution 0.4% varies based on the procedure and patient needs:
Oxycaine Ophthalmic Solution 0.4% is administered topically as eye drops. It should be applied directly to the affected area or as directed by a healthcare professional. Proper aseptic technique should be followed to prevent contamination and ensure effectiveness.
Common side effects may include:
Serious side effects, although rare, can include:
Toxicity can occur with excessive or prolonged use of Oxycaine Ophthalmic Solution 0.4%, leading to corneal damage or systemic effects if absorbed in significant amounts. Symptoms of toxicity include persistent eye pain, blurred vision, or signs of allergic reaction.
Precautions include:
Oxycaine Ophthalmic Solution 0.4% may interact with other topical ophthalmic medications. It is important to inform the healthcare provider of all other eye medications being used to avoid potential interactions.
Use with caution in patients with:
Drug interactions are minimal due to the local application of Oxycaine Ophthalmic Solution 0.4%. However, it is advisable to avoid concurrent use with other ophthalmic anesthetics unless directed by a healthcare provider.
There are no significant food interactions with Oxycaine Ophthalmic Solution 0.4%. Patients can eat and drink normally while using the medication.
Oxycaine Ophthalmic Solution 0.4% is generally used with caution during pregnancy. It should be administered only if the benefits outweigh the risks and under the guidance of a healthcare professional.
Oxycaine Ophthalmic Solution 0.4% is applied topically, and systemic absorption is minimal. It is generally considered safe for use during lactation, but it is advisable to consult with a healthcare provider before use.
Acute overdose is unlikely with topical application. However, if excessive amounts are used or if there is accidental ingestion, immediate medical attention should be sought. Symptoms of overdose may include severe eye irritation or systemic effects if absorbed.
Oxycaine Ophthalmic Solution 0.4% is contraindicated in patients with:
Apply Oxycaine Ophthalmic Solution 0.4% as directed, typically 1 to 2 drops per eye. Avoid overuse and ensure the medication is used under the supervision of a healthcare provider to prevent complications.
Store Oxycaine Ophthalmic Solution 0.4% at room temperature, away from direct light and moisture. Keep it out of reach of children and use before the expiration date indicated on the packaging.
The volume of distribution for Oxycaine Ophthalmic Solution 0.4% is not well-documented due to its topical application and minimal systemic absorption. Its primary action is localized to the site of application.
The half-life of Oxycaine Ophthalmic Solution 0.4% is relatively short, typically around 1 to 2 hours. The duration of action at the site of application is approximately 15 to 30 minutes.
Oxycaine Ophthalmic Solution 0.4% is cleared primarily through the liver, with minimal systemic absorption and therefore limited systemic clearance. The drug's local effects are primarily cleared through natural metabolic processes in the eye.
See in details version Oxycaine Ophthalmic Solution 0.4% also Oxycaine Ophthalmic Solution 0.4% in bangla